Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in ANOCA
NCT06864234Phase 4Recruiting
- Sponsor
- Cardiovascular Research Center Aalst
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metoprolol in Angina with non-obstructive coronary arteries (ANOCA) (2 arms), sponsored by Cardiovascular Research Center Aalst. Primary endpoints: Change from baseline in the absolute coronary flow at 10 minutes, Change from baseline in the absolute microvascular resistance at 10 minutes and 1 more. Started Jul 2025; status: recruiting.
02
Drugs
metoprolol
03
Conditions
Angina with non-obstructive coronary arteries (ANOCA)
Beyond the preview
Go deeper on NCT06864234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06864234.